A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • In the media
  • 医薬品アクセス財団、2021年度版の医薬品アクセ...
Media - published on 27 Jan 2021
Share

医薬品アクセス財団、2021年度版の医薬品アクセスインデックス（ATMインデックス）～貧困層に対する迅速な新薬アクセスに向けた製薬企業の体系的な動きが確認される～

Nikkei Biotechnology & Business, Japan’s largest biotechnology media, underlines the eight pharmaceutical companies with systematic access plans for their pipeline products, as assessed in the 2021 Access to Medicine Index.

Next up: Media

Drugmakers 'inching ahead' in increasing access to drugs worldwide, with GlaxoSmithKline leading the pack

Get in touch

Back to top |